Super Lash Bimatoprost Ophthalmic Solution 0.03% W/V, 3 ml

₹ 399/Bottle

Packaging Size3 ml
Manufactured ByHealing Pharma
BrandSuper Lash
Type Of EyedropsAllopathic
FormSterile Ophthalmic Solution
Strength0.03% w/v
View in Hindi सुपर लैश बिमैटोप्रोस्ट ऑफ्थैल्मिक सॉल्यूशन 0.03% डब्ल्यू/वी, 3 मिली
Super Lash contains Bimatoprost, a prostaglandin analog, primarily used in the treatment of glaucoma and ocular hypertension by reducing intraocular pressure. Additionally, it is widely known for promoting eyelash growth, making lashes longer, thicker, and darker.

Exports To: United States Of America | Canada | United Kingdom | Australia | Germany

Find products similar to Super Lash Bimatoprost Ophthalmic Solution 0.03% W/V, 3 Ml

Find related categories

Shipping Information

AvailabilityIn Stock
PriceExcluding all taxes
Ships fromSurat
ShippingAs per delivery location

Product Image

Super Lash Bimatoprost Ophthalmic Solution 0.03% W/V, 3 ml image 1Super Lash Bimatoprost Ophthalmic Solution 0.03% W/V, 3 ml image 2Super Lash Bimatoprost Ophthalmic Solution 0.03% W/V, 3 ml image 3

About the Company

GST Registration Year
2023
Legal Status of Firm
Proprietorship
Nature of Business
Trader - Retailer
Number of Employees
11 To 25 People
Annual Turnover
0 - 40 L
IndiaMART Member Since
May 2022
GST
24**********1Z7
Import Export Code (IEC)
*******52P
Exports to
United States Of America | Canada | United Kingdom | Australia | Germany
Established in the year of 2018, we “Wellniv Pharma” are Exporter Wholesaler of Antifungal Cream, Pharmaceutical Tablets, Pain Clear Gel & many more. We direct all our activities to cater the expectations of customers by providing them excellent quality products as per their gratification. Moreover, we follow moral business policies and crystal pure transparency in all our transactions to keep healthy relations with the customers.
For our accomplishment story, we are grateful to our Mr. Naresh Beladiya, whose continual backing and direction have been useful to us for attaining exponential development in the current market.